Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Therapeutic approach for patients with venous thromboembolism attended in emergency departments during routine
Pedro Ruiz-Artacho1, Pascual Piñera2, Albert Antolin3
1Emergency Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Aim:
To analyze treatment at discharge/follow-up of patients diagnosed with venous thromboembolism (VTE) in the emergency department (ED).
Materials & Methods:
Ambispective study (50 Spanish centers) of consecutive patients (October-December 2014) with VTE diagnosed in ED.
Results:
VTE was diagnosed in 775 patients (295 pulmonary embolism [PE] without deep vein thrombosis [DVT], 389 DVT without PE and 91 PE + DVT); 95.5% received anticoagulants (90.7% low-molecular-weight heparin [LMWH], 4% LMWH + vitamin K antagonists and <1% direct oral anticoagulants). Overall, 23.3% were discharged from ED and 74.5% hospitalized (98.6% with PE and 50.4% with DVT). After discharge/90/180 days, 43.6/21.0/13.5% were taking LMWH, with similar rates in nononcologic patients.
Conclusion:
There is a poor adherence to international guidelines in management of VTE patients in Spain.
More Related Videos
07:52Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Emerging Adulthood
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Introduction Cardiac Emergencies
Hypertension III: Clinical Manifestations and Diagnostic Studies